Showing 6951-6960 of 20899 results for "".
- DOAC versus VKA after bioprosthetic valve replacementhttps://reachmd.com/news/doac-versus-vka-after-bioprosthetic-valve-replacement/2468632/This summary is based on the presentation of Chisato Izumi, MD, PhD (Suita, Japan) at the AHA Scientific Sessions 2024 - Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early after Surgical Bioprosthetic Valve Replacement: ENBALV trial. Introduction and
- Could Targeting Genetic Variations Help Curb Sugary Food Cravings?https://reachmd.com/news/could-targeting-genetic-variations-help-curb-sugary-food-cravings/2468609/Researchers have uncovered a potential link between genetic variations in the sucrase-isomaltase (SI) gene and an individual’s preference for sugary foods, revealing new possibilities for reducing sugar cravings and intake. This study, led by a team from the University of Nottingham and involving
- Racial Disparities in Post-Surgical Pain Management Highlighted in New Studyhttps://reachmd.com/news/racial-disparities-in-post-surgical-pain-management-highlighted-in-new-study/2468613/New research presented at the ANESTHESIOLOGY® 2024 annual meeting reveals that Black patients are less likely than white patients to receive multimodal analgesia—a combination of pain management drugs—after major surgeries. Instead, Black patients are more frequently prescribed
- Zasocitinib Demonstrates Efficacy in Moderate to Severe Psoriasis Treatmenthttps://reachmd.com/news/zasocitinib-demonstrates-efficacy-in-moderate-to-severe-psoriasis-treatment/2468607/A recent phase 2b trial of zasocitinib, a selective TYK2 inhibitor, demonstrated promising results in treating moderate to severe plaque psoriasis. Conducted across multiple centers in the U.S. and Canada, the study included 259 participants who received zasocitinib at varying doses (2, 5, 15, an
- Analyses: Ruxolitinib Cream Reduces AD Symptom Burden in 12 Hourshttps://reachmd.com/news/analyses-ruxolitinib-cream-reduces-ad-symptom-burden-12-hours/2468615/Ruxolitinib cream significantly reduced skin pain and improved patient-reported outcomes (PROs) in individuals with mild-to-moderate atopic dermatitis (AD), with improvements sustained over 52 weeks, according to data from the TRuE-AD1 and TRuE-AD2 studies. Researchers the results publishi
- Modifiable Risk Factors Linked to Stroke Severityhttps://reachmd.com/news/modifiable-risk-factors-linked-to-stroke-severity/2468592/New research highlights the significant role of modifiable risk factors like high blood pressure, atrial fibrillation, and smoking in determining stroke severity. Published in Neurology, the American Academy of Neurology’s medical journal, this study suggests that individuals with these
- New Research Links Childhood Asthma to Memory Challengeshttps://reachmd.com/news/new-research-links-childhood-asthma-to-memory-challenges/2468586/A recent study has identified a connection between asthma and memory difficulties in children, marking the first time these two conditions have been formally linked. Published in JAMA Network Open, the findings suggest that children with asthma may have a reduced ability to remember spec
- New Study Finds No Association Between Tobacco Smoke and Childhood Atopic Dermatitishttps://reachmd.com/news/new-study-finds-no-association-between-tobacco-smoke-and-childhood-atopic-dermatitis/2468587/A new study has found no evidence linking tobacco smoke exposure (TSE) to atopic dermatitis (AD) in children and adolescents. Following 10,521 individuals as part of the Avon Longitudinal Study of Parents and Children, researchers examined both active and passive TSE but observed no association w
- New Study Reveals Lifelong Factors in Healthy Brain Aginghttps://reachmd.com/news/new-study-reveals-lifelong-factors-in-healthy-brain-aging/2468594/A landmark 25-year research project has uncovered important insights into how brains age, revealing that cognitive resilience or decline can be significantly influenced by factors established as early as childhood. This study, conducted by the University of Edinburgh and published in Genomic
- New Study Shows Virtual Cognitive Behavioral Therapy Reduces Suicide Risk in High-Risk Adultshttps://reachmd.com/news/new-study-shows-virtual-cognitive-behavioral-therapy-reduces-suicide-risk-in-high-risk-adults/2468596/As suicide rates continue to climb worldwide, mental health researchers are exploring innovative ways to reach those at risk. A new study from Ohio State University Wexner Medical Center and College of Medicine has found that delivering brief cognitive behavioral therapy (CBT) via video telehealt